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Background: Single-centre series of the management of patients with ruptured abdominal aortic
aneurysm (AAA) are usually too small to identify clinical factors that could improve patient outcomes.
Methods: IMPROVE is a pragmatic, multicentre randomized clinical trial in which eligible patients with
a clinical diagnosis of ruptured aneurysm were allocated to a strategy of endovascular aneurysm repair
(EVAR) or to open repair. The influences of time and manner of hospital presentation, fluid volume
status, type of anaesthesia, type of endovascular repair and time to aneurysm repair on 30-day mortality
were investigated according to a prespecified plan, for the subgroup of patients with a proven diagnosis
of ruptured or symptomatic AAA. Adjustment was made for potential confounding factors.
Results: Some 558 of 613 randomized patients had a symptomatic or ruptured aneurysm: diagnostic
accuracy was 91·0 per cent. Patients randomized outside routine working hours had higher operative
mortality (adjusted odds ratio (OR) 1·47, 95 per cent confidence interval 1·00 to 2·17). Mortality rates
after primary and secondary presentation were similar. Lowest systolic blood pressure was strongly
and independently associated with 30-day mortality (51 per cent among those with pressure below 70
mmHg). Patients who received EVAR under local anaesthesia alone had greatly reduced 30-day mortality
compared with those who had general anaesthesia (adjusted OR 0·27, 0·10 to 0·70).
Conclusion: These findings suggest that the outcome of ruptured AAA might be improved by wider use
of local anaesthesia for EVAR and that a minimum blood pressure of 70 mmHg is too low a threshold
for permissive hypotension.
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Introduction
Ruptured abdominal aortic aneurysm (AAA) is fatal with-
out emergency surgical intervention. Although patients
typically present with a cluster of characteristic symptoms,
including collapse and back pain, in older people the differ-
ential diagnosis can be wide. Unlike myocardial infarction
or stroke, the diagnosis cannot be made in the ambulance
that brings most of these patients to hospital. Therefore,
many patients still present in emergency departments of
hospitals that do not offer emergency AAA repair. There
is evidence that operative mortality after rupture is lower
in larger-volume vascular centres1 and that, in England,
operative mortality for all types of emergency surgery is
lower if patients present within working hours2. However,
even larger-volume centres cannot offer sufﬁciently sized
prospective case series in which to investigate hospital and
clinical factors that may be associated with better patient
outcomes. To date, the largest series3 on endovascular
repair reported on 473 patients treated between 1998 and
2011 from centres in two countries. The supposed bene-
ﬁts of endovascular aneurysm repair (EVAR) in reducing
operative mortality have been questioned recently, with
a randomized trial4 of endovascular versus open repair
for AAA rupture (all anatomically suitable for endovascu-
lar repair) showing no difference in operative mortality
between the groups.
The Immediate Management of Patients with Ruptured
Aneurysm: OpenVersus Endovascular Repair (IMPROVE)
trial (ISRCTN 48334791; http://www.controlled-
trials.com) recruited eligible patients with a clinical
diagnosis of AAA rupture between late 2009 and summer
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2013. This prospective cohort was used to investigate
the role of factors such as hospital presentation, time to
surgery, ﬂuid replacement therapy and type of anaesthesia
on the early outcomes of emergency surgery. Patients
whose initial diagnosis of rupture was unsubstantiated also
provided insight into the range of differential diagnoses.
The aim of this paper was to investigate the details of
clinical practice that could be used to beneﬁt future
patients with ruptured AAA.
Methods
The detailed trial methodology and principal out-
comes have been published elsewhere (http://www.
improvetrial.org)5,6. IMPROVE is a multicentre random-
ized trial designed to test the hypothesis that an endovas-
cular strategy (immediate computed tomography (CT) and
emergency EVAR if anatomically feasible) provides a sur-
vival advantage for patients with ruptured AAA compared
with the standard treatment of emergency open repair
(including CT at the clinicians’ discretion). This trial was
open to eligible centres in the UK and elsewhere. The
eligibility of each centre to participate in the trial was
determined by their clinical credentials, which included
audited volumes of elective EVAR of at least 20 cases
per year, of at least 50 aortic procedures, evidence of good
interdisciplinary teamworking, team availability for at least
66 per cent of the week, rapid access to emergency CT
(target 20min), and audited experience of EVAR for rup-
tured and/or acute aneurysms (minimum of 5 procedures).
Each centre nominated a lead clinician with Good Clinical
Practice training (usually a surgeon or interventional radi-
ologist), an emergency care physician and an anaesthetist
(particularly for the training of junior staff).
All patients with a clinical diagnosis of ruptured AAA
or ruptured aortoiliac aneurysm, made by a senior trial
clinician, were eligible for inclusion, unless they were
moribund and intervention was considered futile. The
patient could be diagnosed and considered for random-
ization by either a senior member of the emergency team
or a senior member of the vascular team at the trial
hospital. In all cases, including hospital transfers, the
patient had to be considered for randomization before
CT ﬁndings had been assessed for EVAR suitability by
the local intervention team. There were protocols for
care in the emergency department, to minimize delays in
recognizing the diagnosis, limiting unnecessary investiga-
tions, maintaining hypotensive haemostasis (target systolic
pressure 70–80mmHg) with a protocol of 250-ml ﬂuid
bolus resuscitation7,8, and arranging prompt attention
by the vascular team, irrespective of allocated treatment.
The minimum investigations included those necessary to
obtain a Hardman index score9, electrocardiography, mea-
surement of haemoglobin and creatinine levels, together
with testing blood for cross-matching. The choice of
anaesthesia, aortic stent-graft and open surgical approach
(including site of aortic clamping) was at the discretion of
the intervention team. All data were collected on electronic
case report forms that were held in a central trial database
and copies of admission CT were collected for analysis in
the core laboratory at St George’s Hospital, London.
Patients were excluded if they were younger than
50 years, had undergone AAA repair previously, had
rupture of an isolated internal iliac aneurysm, had an
aortocaval or aortoenteric ﬁstula, had undergone recent
assessment by aortic CT (were awaiting elective EVAR),
or were known to have a connective tissue disorder (such
as Marfan syndrome); those in whom intervention was
considered futile (patient moribund) were also excluded.
The guidelines and protocols for the trial are avail-
able on the trial website (www.imperial.ac.uk/medicine/
improvetrial)5. Ethical approval for the participation of
patients in England and Wales was received from Berk-
shire National Research Ethics Service Committee, in
Scotland from Scotland A Research Ethics Committee and
in Canada from University of Western Ontario Health
Sciences Research Ethics Board. Further approval for the
use of routine data for patients lost to follow-up in England
and Wales was obtained from the National Information
Governance Board.
The diagnosis of AAA rupture for the purposes of
the trial was made from one of the following ﬁndings:
review of CT in the core laboratory (if this disagreed with
local opinion, two further expert opinions were sought);
observation of rupture at open repair; or death certiﬁcate,
with or without post-mortem examination.
In the Amsterdam Acute Aneurysm (AJAX) trial4 the
time taken for a patient to reach the operating theatre
was on average 47–74min, so routine working hours were
deﬁned by randomization as between 08.00 and 16.00 hours
from Monday to Friday; out-of-hours comprised the
remainder of the week.
Apart from the prespeciﬁed trial outcomes, a number
of clinically driven hypotheses were generated by the
trial management committee before data analysis. These
included both preoperative and intraoperative factors.
Speciﬁcally, it was hypothesized that, even when adjusted
for Hardman index, age, sex, randomized group and
aneurysm diameter: outcomes may be better for patients
randomized within routine working hours; patients trans-
ferred fromother hospitals to trial centreswould have lower
Hardman scores and better outcomes than those arriving
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primarily at the trial centre; lowest blood pressure would
not be associated with 30-day survival because overadmin-
istration of ﬂuid and/or blood products is associated with
highermortality rates; general anaesthesia for endovascular
repair may be associated with higher operative mortality
compared with local anaesthesia; and centres treating
larger numbers of ruptured AAA have more practised and
skilled teams with improved patient survival rates.
Statistical analysis
A statistical analysis plan was published on the trial websites
before any data were analysed. Continuous variables
were analysed by means of the t test and categorical
variables using the χ2 test. Overall 30-day mortality
rates were calculated from the time of randomization.
Logistic regression was used to make primary adjustments
for randomized group, age, sex, Hardman index and
maximum aortic diameter, and secondary adjustment
including other variables. Multiple imputation was used as
necessary in the presence of missing values. The effect of
routine working hours versus out-of-hours randomization
on the effectiveness of the EVAR strategy was assessed
by including an interaction term. Three patients had
lowest systolic blood pressure below the limit of detection
and their values were set to 33mmHg (5mmHg below
the lowest recorded value). As these analyses were not
speciﬁed in the original trial protocol and represent
observational associations, the results must be interpreted
with caution. Odds ratios (ORs) are presented with 95 per
cent conﬁdence intervals (c.i.).
Results
Clinical diagnostic accuracy
Of 613 eligible patients (600 from the UK and 13 from
Canada), the diagnosis of rupture was conﬁrmed in 536
patients and a further 22 underwent same-admission repair
of a symptomatic aneurysm. This provided a cohort of
558 patients eligible for emergency or urgent aneurysm
repair, 283 assigned to an endovascular strategy and 275
to open repair. A total of 55 patients had a discharge
diagnosis that was not aneurysm-related, although 45 of
these had an asymptomatic aneurysm. Clinical diagnostic
accuracy was 91·0 per cent (558 of 613) for ruptured and
symptomatic aneurysm, and 87·4 per cent (536 of 613)
for ruptured aneurysm only. The most common other
discharge diagnosis was a gastrointestinal disorder (15 of
55) followed by other vascular and genitourinary disorders
(each 9 of 55). Four patients had a ruptured thoracic aortic
Table 1 Discharge diagnoses and incidental aneurysms in 55
patients without either ruptured or symptomatic abdominal
aortic aneurysm
Diagnosis Incidental AAA (n= 45) No AAA (n =10)
Ruptured thoracic aneurysm 4 0
Ischaemic heart disease 4 0
Other vascular 7 2
Genitourinary 5 4
Pulmonary 5 0
Gastrointestinal 11 4
Other 9 0
AAA, abdominal aortic aneurysm.
aneurysm and four had ischaemic heart disease (Table 1);
there was a wide range of other discharge diagnoses.
Baseline data, operative details and mortality
at 30 days after randomization
These data are summarized in Table 2 for all 558 patients
with ruptured or symptomatic AAA. The 30-day mortality
rate was 35·7 per cent (101 of 283) in the endovascular
strategy group and 39·3 per cent (108 of 275) in the open
repair group.The effect of the primary adjustment variables
(age, sex, Hardman index and maximum aortic diameter)
is shown in Table 3: the expected prognostic value of the
Hardman index is observed. The effect of other variables
is shown in Table 4.
Time of presentation
Overall, patients randomized out-of-hours had a higher
mortality risk (primary adjusted OR 1·47, 95 per cent
c.i. 1·00 to 2·17; P = 0·048), although this reduced
to borderline signiﬁcance after further adjustment for
lowest recorded systolic pressure and volume of ﬂuids
administered (Table 4). There was also little evidence
that the efﬁcacy of the endovascular strategy versus open
repair was different in patients randomized out-of-hours
compared with those randomized in routine working hours
(test of interaction, P = 0·100).
Patient transfers: primary versus secondary
presentation
The characteristics of patients with direct and secondary
presentation to trial centres, including Hardman index,
were similar, although a greater proportion of referred
patients were randomized out-of-hours (Table 5). There
was no difference in 30-day mortality between the
221 admitted directly to the trial centre versus the 335
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Table 2 Baseline characteristics, operative details and 30-day
mortality among 558 patients with ruptured or symptomatic
abdominal aortic aneurysm
No. of missing
values
30-day mortality
(n= 558)
Age (years) 0
< 65 10 of 43 (23·3)
65–74 51 of 190 (26·8)
75–84 97 of 245 (39·6)
≥85 51 of 80 (63·8)
Sex 0
F 59 of 117 (50·4)
M 150 of 441 (34·0)
Hardman index (0–5) 64
0 27 of 148 (18·2)
1 96 of 234 (41·0)
2 48 of 88 (54·5)
≥ 3 13 of 24 (54·2)
Randomized group 0
Endovascular strategy 101 of 283 (35·7)
Open repair 108 of 275 (39·3)
Maximum aortic diameter (cm)* 69
< 7·0 42 of 104 (40·4)
7·0–7·9 41 of 99 (41·4)
8·0–8·9 45 of 116 (38·8)
9·0–9·9 30 of 94 (31·9)
≥ 10·0 22 of 76 (28·9)
Time of randomization 0
Out-of-hours 144 of 362 (39·8)
Routine working hours 65 of 196 (33·2)
Presentation to hospital 2
Direct 87 of 221 (39·4)
Transferred from another hospital 122 of 335 (36·4)
Lowest recorded systolic blood
pressure (mmHg)†
35
< 70 48 of 95 (50·5)
70–83 43 of 114 (37·7)
84–98 47 of 103 (45·6)
99–119 29 of 101 (28·7)
≥ 120 27 of 110 (24·5)
Total volume of i.v. fluids given before
arrival in theatre (litres)‡
256
≤ 0·5 21 of 63 (33·3)
0·6–1·0 52 of 124 (41·9)
1·1–2·0 31 of 72 (43·1)
≥ 2·1 21 of 43 (48·8)
Time from randomization to
theatre (min)§
5
< 25 49 of 128 (38·3)
25–44 46 of 136 (33·8)
45–69 43 of 117 (36·8)
≥ 70 34 of 118 (28·8)
Anaesthetic used for EVAR¶ 4
General 28 of 83 (33·7)
Local then general 9 of 30 (30·0)
Local only 9 of 69 (13·0)
Procedure received
EVAR 9# 46 of 186 (24·7)
Aortouni-iliac 12 of 36 (33·3)
Bifurcated 29 of 135 (21·5)
Tube 1 of 6 (16·7)
Table 2 Continued
No. of missing
values
30-day mortality
(n= 558)
EVAR converted to open 4 of 4 (100)
Open repair 37# 124 of 332 (37·3)
Aortouni-iliac 1 of 4 (25·0)
Bifurcated 14 of 54 (25·9)
Tube 87 of 237 (36·7)
No operation 35 of 36 (97·2)
Values in parentheses are percentages. *Includes diameter of common
iliac aneurysm when ruptured observed here. †Lowest recorded between
admission and entry to operating suite. ‡Any intravenous (i.v.) infusion
including blood and blood products. §Only for 504 patients with ruptured
abdominal aortic aneurysm who arrived at theatre alive. ¶Only for 186
patients who had endovascular aneurysm repair (EVAR). #Graft type
missing.
Table 3 Adjusted effect of main variables on 30-day mortality in
558 patients
Odds ratio P†
Age (per 5-year increase)* 1·20 (1·04, 1·38) 0·015
Sex
F 1·00
M 0·72 (0·45, 1·14) 0·162
Hardman index (per 1-unit
increase)
1·62 (1·26, 2·08) < 0·001
Randomized group
Open repair 1·00
Endovascular strategy 0·89 (0·62, 1·28) 0·535
Maximum aortic diameter
(per 1-cm increase)
0·94 (0·83, 1·06) 0·292
Values in parentheses are 95 per cent conﬁdence intervals (c.i.). *Not full
effect of age as dichotomized age included in Hardman index. Odds ratio
of age (per 5-year increase) after exclusion of Hardman index from
adjustment list was 1·37 (95 per cent c.i. 1·21 to 1·56) (P< 0·001). †Z test.
transferred from other hospitals (adjusted OR 0·76, 0·52
to 1·12).
Preoperative variables: fluids, blood pressure
and time from randomization to operating suite
The volume of ﬂuids administered before arrival in the
operating theatre was recorded in only 302 patients. The
relationship to lowest in-hospital preoperative measured
systolic blood pressure is shown in Fig. 1 for 296 patients
who had both variables recorded. Patients were divided
into quintiles according to the lowest recorded blood
pressure before arrival in the operating theatre. There
appeared to be a trend towards increasing ﬂuids given
with decreasing lowest recorded blood pressure; the
effect of ﬂuids administered on 30-day mortality was not
signiﬁcant in the multivariable adjusted model (Table 4).
In contrast, the lowest systolic blood pressure recorded
in hospital before operation (distribution in Fig. 2a) was
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Table 4 Odds ratios for 30-day mortality with primary adjustment for age, sex, Hardman index, randomized group and maximum
aneurysm diameter
Secondary adjusted
analysis#
No. of patients*
Unadjusted
odds ratio
Primary adjusted
odds ratio¶ Odds ratio P††
Time of randomization 558
Routine working hours 1·00 1·00 1·00
Out-of-hours 1·33 1·47 1·40 (0·94, 2·08) 0·096
Presentation to hospital 556
Primary 1·00 1·00 1·00
Secondary 0·88 0·84 0·76 (0·52, 1·12) 0·170
Lowest recorded systolic blood pressure (per
10-mmHg increase)
558 0·87 0·87 0·88 (0·82, 0·94) < 0·001
Total volume of i.v. fluids given before arrival
in theatre (per 1-litre increase)
558 1·24 1·19 1·18 (0·86, 1·60) 0·289
Time from randomization to theatre
(per quartile increase)†
499
0·89 0·89 0·93 (0·77, 1·11) 0·415
Anaesthetic used‡ 182 n= 175**
General 1·00 1·00 1·00
Local then general 0·84 0·74 0·74 (0·25, 2·22) 0·596
Local only 0·29 0·25 0·27 (0·10, 0·70) 0·007
Graft type used‡ 177 n= 175**
Bifurcated 1·00 1·00 1·00
Aortouni-iliac 1·83 1·79 1·46 (0·54, 3·94) 0·457
Tube 0·73 0·53 0·78 (0·07, 9·30) 0·843
Rate of patients with ruptured AAA presenting
to centre (per patient per month increase)§
543 0·96 0·99 0·93 (0·65, 1·32) 0·674
Percentage of included patients (per 25 per
cent increase)§
544 1·13 1·07 1·06 (0·86, 1·31) 0·591
Values in parentheses are 95 per cent conﬁdence intervals. *Number used in analysis (multiply imputed data used for lowest recorded systolic blood
pressure and volume of intravenous (i.v.) ﬂuids given). †Includes only patients with ruptured abdominal aortic aneurysm (AAA) who reached the
operating theatre alive; quartiles are shown in Table 2. ‡Only patients who had endovascular aneurysm repair (EVAR). §Excludes four centres with
incomplete information on number not randomized. ¶Adjusted for core variables: age, sex, Hardman index, randomized group and maximum aortic
diameter. #Adjusted for core variables, time of randomization, lowest recorded systolic blood pressure and total volume of i.v. ﬂuids administered; **in
patients who received EVAR, models were further adjusted for anaesthetic used and graft type. ††Z test.
Table 5 Comparison of baseline data for primary and secondary presentation at participating hospitals
Mode of arrival
No. of missing values
Direct presentation
(n= 221)
Transferred from another hospital
(n= 335) P†
Mean age (years)* 0 76·5(6·9) 76·5(7·9) 0·928
Sex ratio (M : F) 0 167 : 54 272 : 63 0·111‡
Hardman index 63 0·521‡
0 63 (32·0) 84 (28·4)
1 96 (48·7) 138 (46·6)
2 28 (14·2) 60 (20·3)
≥ 3 10 (5·1) 14 (4·7)
Lowest recorded systolic blood pressure before
transfer to CT or theatre (mmHg)*
35 96·1(33·2) 93·6(27·4) 0·354
Maximum aortic diameter (cm)* 69 8·3(1·7) 8·4(1·6) 0·878
Randomized out-of-hours 0 127 (57·5) 233 (69·6) 0·004‡
Values in parentheses are percentages unless indicated otherwise; *values are mean(s.d.). CT, computed tomography. †t test, except ‡χ2 test.
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Fig. 1 Relationship between mean volume of ﬂuids administered
before arrival in the operating suite and lowest recorded systolic
blood pressure, by quintiles of blood pressure, in 296 patients.
Error bars represent 95 per cent conﬁdence intervals
signiﬁcantly associated with 30-day mortality, without
any evidence of non-linearity (Fig. 2b). This association
was independent of the volume of intravenous ﬂuids
administered: adjusted OR per 10-mmHg increase in
blood pressure 0·88 (0·82 to 0·94). The 30-day mortality
rate among patients with lowest systolic blood pressure
above and below the threshold value of 70mmHg was
34·1 and 51 per cent respectively. For 536 patients with
conﬁrmed rupture, the time from randomization to the
operating suite was not associated with 30-day mortality
(P = 0·415).
Operative variables
Overall, among the 186 patients who underwent EVAR,
there appeared to be a substantially lower 30-day mortality
associated with procedures conducted under local anaes-
thesia only. After adjustment, local anaesthesia was associ-
ated with a fourfold reduction in 30-daymortality (adjusted
OR 0·27, 0·10 to 0·70; P = 0·007). Local anaesthesia was
more commonly used with bifurcated graft conﬁgurations,
whereas general anaesthesia wasmore frequently employed
with aortouni-iliac conﬁgurations (Table S1, supporting
information). Therefore, after adjustment for anaesthetic
use, graft conﬁguration was not associated with 30-day
mortality (Table 4).
Centre volume and recruitment to the trial
The comprehensive logging of 652 non-recruited patients
with ruptured aneurysm permitted assessment of the effect
of centre volume and percentage recruitment to the trial
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Fig. 2 a Lowest recorded systolic blood pressures in 520 patients
(three further patients had unrecordable blood pressure) and
b effect of systolic blood pressure (lowest recorded) on
probability of 30-day mortality. Error bars represent 95 per cent
conﬁdence intervals
on 30-day mortality. There was no evidence that 30-day
mortality was inﬂuenced by either centre volume or the
percentage of patients with ruptured aneurysm who were
recruited (Table 4).
Discussion
These data from the IMPROVE trial have identiﬁed a
number of areas of clinical practice that might beneﬁt
the everyday management of patients with ruptured
aneurysm. The key clinical issues that might immediately
affect patient survival concern the management of
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preoperative blood pressure and the choice of anaesthesia
for endovascular repair, in addition to the choice of
endovascular reconstruction7.
Patients were entered into the trial on the basis of
a clinical diagnosis of ruptured AAA made by a senior
clinician. The trial therefore offered a unique opportunity
to assess the accuracy of the in-hospital clinical diagnosis
of ruptured AAA. Approximately one in ten patients with a
clinically suspected ruptured AAA was found to have alter-
native pathology at either laparotomy or cross-sectional
imaging, explaining their emergency presentation, even
though the majority of these had an incidental AAA. Given
that patients were diagnosed by an experienced clinician
(and that some may have undergone ultrasound imaging or
CT in another hospital), the diagnostic accuracy is likely to
be signiﬁcantly worse in everyday clinical practice. There-
fore, it is reasonable to suggest that patients should not
undergo attempted repair of a clinically suspected ruptured
AAA without conﬁrmatory imaging studies (usually CT).
Interestingly, even 90 per cent of the patients randomized
to open repair underwent preoperative CT6, suggesting
that cross-sectional imaging is now part of routine
clinical practice.
Although some patients require urgent treatment owing
to haemodynamic decompensation (and pathways should
be in place to facilitate rapid transfer), IMPROVE trial
data suggest that, for most patients, there is sufﬁcient
time to permit conﬁrmatory CT and appropriate further
investigations6. Data from the present trial demonstrated
that patients randomized to the endovascular strategy
group had on average a delay of an additional 10min
between randomization and transfer to the operating room.
This interval, althoughmuch shorter than the 30-min delay
observed in the AJAX trial4, could be clinically signiﬁcant
as a number of patients due to receive endovascular repair
eventually required open repair because of physiological
deterioration. As most patients in the trial, irrespective of
randomized group, underwent CT, the delay was most
likely related to the challenging logistics of providing a
24/7 endovascular service. The IMPROVE trial results
suggest that formalizing the patient pathway for EVAR
might reduce the delay to deﬁnitive therapy.
Patients with ruptured AAA are increasingly being
managed in large centralized vascular units. Consequently
many patients with a clinical diagnosis of rupture are
transferred from smaller hospitals. There was no evidence
of inferior outcomes for patients transferred to the trial
centres compared with those who presented directly,
even after adjustment for Hardman index. This may be
subject to confounding if only the most haemodynamically
stable patients were accepted for transfer and there was
an increased percentage of transferred patients who were
recruited out-of-hours. Such confounders underscore the
need to use universally accepted criteria for transfer, and to
develop local pathways to ensure that appropriate patients
reach vascular centres rapidly10,11.
Systolic blood pressure was found to be a useful and
simple predictor of 30-day outcome. The Hardman index
is more complicated, comprising ﬁve factors (not including
systolic blood pressure) that reliably predict outcome; none
of the ﬁve factors assessed shock directly. Other scoring
systems, such as the Glasgow Aneurysm Score12, include
shock, but these are really designed for audit purposes
rather than as prospective prognostic tools.
Recent publications3,7,13,14 on the management of
ruptured AAA have suggested that intravenous ﬂuid should
be restricted (permissive hypotension, target systolic
pressure 70–80mmHg) to prevent further bleeding and
optimize outcomes. In the present trial, the 30-day
mortality rate was 51 per cent among patients with a lowest
recorded systolic pressure of less than 70mmHg and 34·1
per cent in those with a blood pressure above 70mmHg.
Systolic blood pressure was directly related to outcome in
a linear fashion, with each 10-mmHg increase translating
to a 13 per cent relative improvement in odds of survival.
These data cannot give deﬁnitive guidance on the optimal
systolic blood pressure in patients with ruptured AAA
during the preoperative phase, but may suggest that the
previously recommended threshold of 70mmHg is too low,
particularly in the older patient with other cardiovascular
diseases and high cardiovascular resistance.
The IMPROVE trial centres were high-volume vascular
centres and were credentialled to ensure that there was
good team working and pathways of care for both open
and endovascular surgery. There was no evidence of a
signiﬁcant difference in outcomes between the trial centres
according to their recruitment rate.
The type of anaesthesia used for EVAR appeared to
be important, with local anaesthesia associated with a
signiﬁcant fourfold survival beneﬁt compared with general
anaesthesia, even when adjusted for age, sex, Hardman
index and other factors. Clearly this relationship exists only
for EVAR but the potential beneﬁt appears considerable.
There are no other good clinical trial data to support
local anaesthesia as the method of choice for endovascular
repair of ruptured AAA, but authors with a large experience
in this ﬁeld advocate the use of local anaesthesia3,7. The
magnitude of the survival beneﬁt in the IMPROVE trial
data suggests that local anaesthesia should become ﬁrst
choice. General anaesthesia has signiﬁcant haemodynamic
consequences in patients with ruptured AAA and this may
explain some of the effect.
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Another important issue for clinical practice is whether
aortouni-iliac or bifurcated endografts are better for
treatment of ruptured AAA6. A post hoc analysis suggested
that the 30-day mortality rate was higher in those who had
aortouni-iliac endografts than in those who had bifurcated
endografts: 33 per cent (12 of 36) versus 21·5 per cent (29
of 135) respectively. After adjustment, the higher mortality
risk associated with aortouni-iliac endografts was not
statistically signiﬁcant (OR 1·46, 0·54 to 3·94; P = 0·457).
This higher mortality rate from use of aortouni-iliac grafts
has been conﬁrmed by experienced single centres and a
systematic review7,13,14.
These analyses have a number of limitations. Foremost,
they are observational and all the results need to be
interpreted with care. Although the data have been adjusted
for available factors, the analyses could still be confounded
by patient selection. However, it is reassuring that the
main ﬁndings, for example those for blood pressure and
anaesthesia, are robust to different levels of adjustment
for confounders (Table 4). The trial was pragmatic and,
in an emergency setting, non-essential data such as ﬂuid
volume administration and adjunct clinical treatments were
at the discretion of the local centre. Therefore, there
are no additional details concerning type of anaesthesia
used.
These analyses have raised a number of provocative
issues, but all the results need to be interpreted with care.
First, they suggest that CT should be recommended for all
patients with suspected aneurysm rupture; only one patient
in the IMPROVE trial died before completion of CT. Sec-
ond, systolic blood pressure is an important prognostic
marker for patients with ruptured AAA, and ﬂuid replace-
ment therapy is not an indicator of outcomes when data are
adjusted for blood pressure. The lower the blood pressure,
the higher themortality risk; these results questionwhether
the 70-mmHg threshold used for injured patients8 and the
70–80-mmHg threshold recommended for hypotensive
haemostasis for ruptured aneurysm7 really should be used,
particularly in an elderly cohort with aneurysm rupture.
Third, it may be best to conduct endovascular repair under
local anaesthesia wherever possible, although best-practice
protocols remain to be deﬁned. The beneﬁts of local anaes-
thesia and the worse results of open repair out-of-hours
suggest the need for more specialist anaesthesia services
for patients with aneurysm rupture. Finally, a skilled mul-
tidisciplinary team to conduct emergency vascular surgery
should be available throughout the week, to optimize
results out-of-hours for ruptured aneurysms and other
vascular emergencies such as acute limb ischaemia and
trauma.
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Editor’s commentary
AJAX and IMPROVE are indeed landmark trials that will help deﬁne optimal management of ruptured AAA for
a generation. The authors and their funders are to be congratulated. And yet, both are negative trials: the
primary endpoint (death at 30 days) was not better for the new treatment (EVAR) over standard management
with open surgical repair (see Scientiﬁc Surgery for primary sources). Arguably, Collin and Murie were not so
wrong when they called EVAR a failed experiment (Br J Surg 2001; 88: 1281–1282), though the same challenge
could be aimed at laparoscopic and, more recently, robotic abdominal surgery. But the results should be seen in
the context of modern surgery, with progress from open to minimally invasive treatments, as expected by
patients, for other quality of life beneﬁts. The big question is a process one. For countries that do not have a
coherent plan to deal with emergency AAA, should you invest in a process of vascular centralization to deliver an
emergency EVAR service, or do you invest in population screening for AAA to reduce the rates of AAA rupture?
J. J. Earnshaw
Editor, BJS
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on behalf of BJS Society Ltd.
